Castle Biosciences, Inc. (CSTL) Stock Overview
Explore Castle Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Castle Biosciences, Inc. (CSTL)
Key Financials
Key Financials
Market Cap
928.7M
P/E Ratio
-46.60
EPS (TTM)
$-0.44
ROE
-0.04%
CSTL Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Castle Biosciences, Inc. (NASDAQ: CSTL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Castle Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CSTL on the NASDAQ shows an RSI of 72.27, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $32.90 for the NASDAQ listing.
Key metrics behind Castle Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -46.60 and a market capitalization of 928.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CSTL on the NASDAQ.